Medical News

RSS

Researchers to receive $3 million grant to better understand, minimize effects of stroke in children

Researchers at the University of Colorado Denver | Anschutz Medical Campus, already focused on understanding and minimizing the effects of stroke in children, will receive $3 million as part of a national effort to better understand stroke.

14 Mar 2014

Consumers with canceled insurance exempted from individual mandate through 2016

Those who lost coverage because insurers canceled their plans have been given a hardship exemption through October 2016 from the requirement to have health insurance or pay a fine, Fox News reports. Other stories look at rising medical identity theft and the frustration of a cancer survivor who enrolled in a plan based on misinformation that her doctor was included in its network.

14 Mar 2014

FDA approves expansion of BIOTRONIK's ongoing ProMRI trial

BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today that the Food and Drug Administration has approved the expansion of BIOTRONIK's ongoing ProMRI trial. The new phase of the trial (Phase C) will study the company's ProMRI technology in implantable cardioverter-defibrillator (ICD) devices.

14 Mar 2014

Venaxis' APPY1 Test for appendicitis shows positive results in pivotal U.S. study

Venaxis, Inc., an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1 Test, a rapid, multiple biomarker-based assay for identifying patients that are at low risk for appendicitis, today announced positive top-line results from its pivotal U.S. study.

14 Mar 2014

Eveon and Leti fabricate smart micro-pump for drug delivery

Eveon and CEA-Leti today announced the demonstration of liquid-pumping for smart drug delivery in the bolus mode using a silicon-based micro-pump fabricated with a standard MEMS process.

13 Mar 2014

Australians it's time to consider a flu vaccination

Although it is still early in the season, NPS MedicineWise is joining other health experts in recommending that people at risk of complications of the flu (influenza) get vaccinated against the illness.

13 Mar 2014

A diet rich in animal protein may protect against age-related decline

Elderly individuals who consume higher levels of animal protein may be reducing their risk of physical, social and intellectual decline in the future, show study findings.

13 Mar 2014

Bruker releases application note for detection of pharmaceutical and personal care products in water using EVOQ LC-MS/MS

Bruker has released an application note detailing a simple and convenient method for the quantification of trace pharmaceutical and personal care products (PPCPs) in clean water, using Bruker’s EVOQ triple quadrupole liquid chromatography mass spectrometer (LC-MS/MS). PPCPs are products used for personal health or cosmetic reasons.

13 Mar 2014

New methods of measuring and monitoring brain temperature

A senior academic will use her inaugural professorial lecture to explain how she has introduced new methods of measuring and monitoring brain temperature to take a new look at the role of fever in the recovery of brain injury patients.

13 Mar 2014

Positive margins have limited impact on RCC outcome

Positive vascular wall margins are not associated with systemic recurrence or cancer-specific survival in patients with nonmetastatic renal cell carcinoma with tumour thrombus, US research shows.

13 Mar 2014

Stress sensitivity adds to psychosis vulnerability

Sensitivity to stress may help to determine whether traumatic life events will lead to psychosis, research suggests.

13 Mar 2014

Distinct motor activity patterns for bipolar depression and mania

Acutely ill patients with bipolar disorder show distinct differences in motor activity regulation during episodes of mania and depression, research indicates.

13 Mar 2014

Japanese PAH patient prognosis ‘good’

Japanese patients respond well to pulmonary arterial hypertension-targeted drugs and may have a good prognosis with long-term survival, study findings suggest.

13 Mar 2014

TFDA approves TaiGen's Taigexyn NDA for treatment of community-acquired bacterial pneumonia

TaiGen Biotechnology Company, Limited today announced that the Taiwan Food and Drug Administration has approved the new drug application (NDA) of Taigexyn (nemonoxacin) oral formulation (500 mg) for the treatment of community-acquired bacterial pneumonia (CAP). With this NDA approval, Taiwan is the first region to grant marketing approval to Taigexyn.

13 Mar 2014

PhotoMedex Q4 2013 revenues up 16% to $63.5 million

PhotoMedex, Inc. today announced financial results for the fourth quarter and full year ended December 31, 2013.

13 Mar 2014

Transamerica obtains 4-star Medicare Part D rating from CMS for 2014

Transamerica continues to provide exceptional value to Medicare customers by obtaining a 4-star Medicare Part D rating from the Centers for Medicare and Medicaid Services for 2014.

13 Mar 2014

Antares Pharma reports total revenue of $4.7 million for fourth quarter 2013

Antares Pharma, Inc. today reported operating and financial results for the fourth quarter and full year ended December 31, 2013.

13 Mar 2014

Study: NGF-containing fibrin glue membrane can promote peripheral nerve regeneration

Complete regeneration is usually very difficult following peripheral nerve damage, though microsurgical techniques have vastly increased the success rate of surgery to repair the injured nerve.

13 Mar 2014

AnaptysBio announces strategic immuno-oncology collaboration with TESARO

AnaptysBio, Inc., a leader in the discovery and development of therapeutic antibodies, today announced a strategic immuno-oncology collaboration with TESARO, Inc., an oncology-focused biopharmaceutical company.

13 Mar 2014

SAGE Therapeutics announces completion of $38 million Series C financing

SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat specialty, critical and orphan central nervous system (CNS) disorders, today announced the successful completion of a $38 million Series C financing. OrbiMed Advisors, LLC, EcoR1 Capital Management, Foresite Capital Management and two undisclosed blue chip public investment funds joined existing investors Third Rock Ventures and ARCH Venture Partners.

13 Mar 2014